Millennium Management
AMBI

Millennium Management’s Ambit Biosciences Corp AMBI Stock Holding History

Millennium Management’s Portfolio AMBI Stock Details AMBI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-100,810
Closed -$1.56M – 4069
2013
Q3 		$1.56M Buy
+100,810
New +$1.34M 0.01% 1838

Other funds holding AMBI

FCMI
Foresite Capital Management I Larkspur, California $21.4M AUM 80.48% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
WC
Wexford Capital West Palm Beach, Florida $690M AUM 57.92% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Millennium Management's AMBI Position: Q4 2013 in Review

Millennium Management sold out of Ambit Biosciences Corp (AMBI) in Q4 2013, closing a stake of 100,810 shares — an estimated $1.56M sold.

Millennium Management first reported a position in AMBI in Q3 2013 and held it in 1 quarter. The position peaked at $1.56M in Q3 2013. 35 funds tracked by Wall St. Rank hold AMBI as of Q4 2013.

  • Millennium Management reported no remaining Ambit Biosciences Corp position as of Q4 2013 after selling out during the quarter.
  • Millennium Management sold 100,810 Ambit Biosciences Corp shares in Q4 2013, an estimated $1.56M.
  • Millennium Management first reported a position in Ambit Biosciences Corp in Q3 2013 and held it in 1 quarter.
  • Millennium Management's Ambit Biosciences Corp position peaked at $1.56M in Q3 2013.
  • 35 funds tracked by Wall St. Rank held Ambit Biosciences Corp as of Q4 2013.

Based on Millennium Management's 13F filing for Q4 2013, filed 14 Feb 2014.